|
1
|
Kobayashi H and Celis E: Peptide epitope
identification for tumor-reactive CD4 T cells. Curr Opin Immunol.
20:221–227. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Campoli M and Ferrone S: HLA antigen
changes in malignant cells: Epigenetic mechanisms and biologic
significance. Oncogene. 27:5869–5885. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haabeth OA, Tveita AA, Fauskanger M,
Schjesvold F, Lorvik KB, Hofgaard PO, Omholt H, Munthe LA, Dembic
Z, Corthay A, et al: How do CD4+ T cells detect and
eliminate tumor cells that either lack or express MHC class II
molecules? Front Immunol. 5:1742014. View Article : Google Scholar
|
|
4
|
Reith W, LeibundGut-Landmann S and
Waldburger JM: Regulation of MHC class II gene expression by the
class II transactivator. Nat Rev Immunol. 5:793–806. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pisapia L, Pozzo GD, Barba P, Citro A,
Harris PE and Maffei A: Contrasting effects of IFNα on MHC class II
expression in professional vs. nonprofessional APCs: Role of CIITA
type IV promoter. Results Immunol. 2:174–183. 2012. View Article : Google Scholar
|
|
6
|
Ting JP and Trowsdale J: Genetic control
of MHC class II expression. Cell. 109(Suppl): S21–S33. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pisapia L, Cicatiello V, Barba P, Malanga
D, Maffei A, Hamilton RS and Del Pozzo G: Co-regulated expression
of alpha and beta mRNAs encoding HLA-DR surface heterodimers is
mediated by the MHCII RNA operon. Nucleic Acids Res. 41:3772–3786.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Corso C, Pisapia L, Citro A, Cicatiello V,
Barba P, Cigliano L, Abrescia P, Maffei A, Manco G and Del Pozzo G:
EBP1 and DRBP76/NF90 binding proteins are included in the major
histocompatibility complex class II RNA operon. Nucleic Acids Res.
39:7263–7275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia X, Lessor TJ, Zhang Y, Woodford N and
Hamburger AW: Analysis of the expression pattern of Ebp1, an
ErbB-3-binding protein. Biochem Biophys Res Commun. 289:240–244.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lessor TJ, Yoo JY, Xia X, Woodford N and
Hamburger AW: Ectopic expression of the ErbB-3 binding protein ebp1
inhibits growth and induces differentiation of human breast cancer
cell lines. J Cell Physiol. 183:321–329. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Wang XW, Jelovac D, Nakanishi T,
Yu MH, Akinmade D, Goloubeva O, Ross DD, Brodie A and Hamburger AW:
The ErbB3-binding protein Ebp1 suppresses androgen
receptor-mediated gene transcription and tumorigenesis of prostate
cancer cells. Proc Natl Acad Sci USA. 102:9890–9895. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Linn D, Liu Z, Melamed J, Tavora
F, Young CY, Burger AM and Hamburger AW: EBP1, an ErbB3-binding
protein, is decreased in prostate cancer and implicated in hormone
resistance. Mol Cancer Ther. 7:3176–3186. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Ali TZ, Zhou H, D’Souza DR, Lu Y,
Jaffe J, Liu Z, Passaniti A and Hamburger AW: ErbB3 binding protein
1 represses metastasis-promoting gene anterior gradient protein 2
in prostate cancer. Cancer Res. 70:240–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Woodford N, Xia X and Hamburger
AW: Repression of E2F1-mediated transcription by the ErbB3 binding
protein Ebp1 involves histone deacetylases. Nucleic Acids Res.
31:2168–2177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y and Hamburger AW: Specificity and
heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated
repression of androgen receptor signalling. Br J Cancer.
92:140–146. 2005. View Article : Google Scholar
|
|
16
|
Sun J, Luo Y, Tian Z, Gu L, Xia SC and Yu
Y: Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid
cystic carcinoma and its clinicopathological relevance. BMC Cancer.
12:4992012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou X, Chen W, Zhang Y, Sun J, Wang Q and
Yu Y: Potential therapeutic strategy for oral squamous cell
carcinoma by ErbB3-binding protein 1 gene transfer. J Cancer Res
Clin Oncol. 136:891–896. 2010. View Article : Google Scholar
|
|
18
|
He HC, Ling XH, Zhu JG, Fu X, Han ZD,
Liang YX, Deng YH, Lin ZY, Chen G, Chen YF, et al: Down-regulation
of the ErbB3 binding protein 1 in human bladder cancer promotes
tumor progression and cell proliferation. Mol Biol Rep.
40:3799–3805. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu B, Xiong Y, Ni R, Wei L, Jiang D, Wang
G, Wu D, Xu T, Zhao F, Zhu M, et al: The downregulation of ErbB3
binding protein 1 (EBP1) is associated with poor prognosis and
enhanced cell proliferation in hepatocellular carcinoma. Mol Cell
Biochem. 396:175–185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Z, Ahn JY, Liu X and Ye K: Ebp1
isoforms distinctively regulate cell survival and differentiation.
Proc Natl Acad Sci USA. 103:10917–10922. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim CK, Nguyen TL, Joo KM, Nam DH, Park J,
Lee KH, Cho SW and Ahn JY: Negative regulation of p53 by the long
isoform of ErbB3 binding protein Ebp1 in brain tumors. Cancer Res.
70:9730–9741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bose SK, Sengupta TK, Bandyopadhyay S and
Spicer EK: Identification of Ebp1 as a component of cytoplasmic
bcl-2 mRNP (messenger ribonucleoprotein particle) complexes.
Biochem J. 396:99–107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou H, Mazan-Mamczarz K, Martindale JL,
Barker A, Liu Z, Gorospe M, Leedman PJ, Gartenhaus RB, Hamburger AW
and Zhang Y: Post-transcriptional regulation of androgen receptor
mRNA by an ErbB3 binding protein 1 in prostate cancer. Nucleic
Acids Res. 38:3619–3631. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou H, Zhang Y and Hamburger AW: EBP1
inhibits translation of androgen receptor mRNA in castration
resistant prostate cancer cells. Anticancer Res. 31:3129–3135.
2011.PubMed/NCBI
|
|
25
|
Squatrito M, Mancino M, Donzelli M, Areces
LB and Draetta GF: EBP1 is a nucleolar growth-regulating protein
that is part of pre-ribosomal ribonucleoprotein complexes.
Oncogene. 23:4454–4465. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Squatrito M, Mancino M, Sala L and Draetta
GF: Ebp1 is a dsRNA-binding protein associated with ribosomes that
modulates eIF2alpha phosphorylation. Biochem Biophys Res Commun.
344:859–868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Zhang Y, Akinmade D and Hamburger AW:
Inhibition of heregulin mediated MCF-7 breast cancer cell growth by
the ErbB3 binding protein EBP1. Cancer Lett. 265:298–306. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie Y, Akpinarli A, Maris C, Hipkiss EL,
Lane M, Kwon EK, Muranski P, Restifo NP and Antony PA: Naive
tumor-specific CD4+ T cells differentiated in vivo
eradicate established melanoma. J Exp Med. 207:651–667. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Quezada SA, Simpson TR, Peggs KS, Merghoub
T, Vider J, Fan X, Blasberg R, Yagita H, Muranski P, Antony PA, et
al: Tumor-reactive CD4+ T cells develop cytotoxic
activity and eradicate large established melanoma after transfer
into lymphopenic hosts. J Exp Med. 207:637–650. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thibodeau J, Bourgeois-Daigneault MC and
Lapointe R: Targeting the MHC class II antigen presentation pathway
in cancer immunotherapy. Oncoimmunology. 1:908–916. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Holling TM, van Eggermond MC, Jager MJ and
van den Elsen PJ: Epigenetic silencing of MHC2TA transcription in
cancer. Biochem Pharmacol. 72:1570–1576. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Fondell JD, Wang Q, Xia X, Cheng
A, Lu ML and Hamburger AW: Repression of androgen receptor mediated
transcription by the ErbB-3 binding protein, Ebp1. Oncogene.
21:5609–5618. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Akinmade D and Hamburger AW: The
ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and
AR-mediated transcription. Nucleic Acids Res. 33:6024–6033. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xia X, Cheng A, Lessor T, Zhang Y and
Hamburger AW: Ebp1, an ErbB-3 binding protein, interacts with Rb
and affects Rb transcriptional regulation. J Cell Physiol.
187:209–217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim CK, Lee SB, Nguyen TL, Lee KH, Um SH,
Kim J and Ahn JY: Long isoform of ErbB3 binding protein, p48,
mediates protein kinase B/Akt-dependent HDM2 stabilization and
nuclear localization. Exp Cell Res. 318:136–143. 2012. View Article : Google Scholar
|
|
37
|
Liu Z, Oh SM, Okada M, Liu X, Cheng D,
Peng J, Brat DJ, Sun SY, Zhou W, Gu W, et al: Human BRE1 is an E3
ubiquitin ligase for Ebp1 tumor suppressor. Mol Biol Cell.
20:757–768. 2009. View Article : Google Scholar :
|
|
38
|
Kwon IS and Ahn JY: p48 Ebp1 acts as a
downstream mediator of Trk signaling in neurons, contributing
neuronal differentiation. Neurochem Int. 58:215–223. 2011.
View Article : Google Scholar
|
|
39
|
Monie TP, Perrin AJ, Birtley JR, Sweeney
TR, Karakasiliotis I, Chaudhry Y, Roberts LO, Matthews S,
Goodfellow IG and Curry S: Structural insights into the
transcriptional and translational roles of Ebp1. EMBO J.
26:3936–3944. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yap DB, Hsieh JK, Chan FS and Lu X: mdm2:
A bridge over the two tumour suppressors, p53 and Rb. Oncogene.
18:7681–7689. 1999. View Article : Google Scholar
|
